A Ginseng-derived nanoparticle preparation was reported to reprogram TAMs, thus leading to the recruitment of CD8+ T cells to the TME and producing a synergistic anti-tumor effect with anti-PD-1 mAb [220]. The gene discussed is CD8A; the disease is neoplasm.